pantoprazole has been researched along with elacridar in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Breedveld, P; Cipriani, G; Pluim, D; Schellens, JH; Schinkel, AH; van Tellingen, O; Wielinga, P | 1 |
| Beijnen, JH; Buckle, T; Oostendorp, RL; Schellens, JH; van Tellingen, O | 1 |
| McNamara, PJ; Wang, L | 1 |
| Belhassan, F; Gizurarson, S; Hada, N; Netzer, WJ; Wennogle, LP | 1 |
5 other study(ies) available for pantoprazole and elacridar
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in pat
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Benzimidazoles; Biological Transport; Brain; Dogs; Drug Synergism; Humans; Imatinib Mesylate; Male; Membranes; Methotrexate; Mice; Mice, Knockout; Neoplasm Proteins; Omeprazole; Pantoprazole; Piperazines; Pyrimidines; Spodoptera; Sulfoxides; Tetrahydroisoquinolines | 2005 |
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Bile; Brain; Drug Combinations; Drug Resistance, Neoplasm; Feces; Female; Imatinib Mesylate; Kidney; Liver; Metabolic Clearance Rate; Mice; Mice, Knockout; Pantoprazole; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tetrahydroisoquinolines | 2009 |
Stereoselective interaction of pantoprazole with ABCG2. I. Drug accumulation in rat milk.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acridines; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Cell Line; Chromatography, High Pressure Liquid; Cross-Over Studies; Dogs; Female; Infusions, Intravenous; Mass Spectrometry; Milk; Pantoprazole; Random Allocation; Rats; Rats, Sprague-Dawley; Stereoisomerism; Tetrahydroisoquinolines | 2012 |
Nose-to-brain transport of imatinib mesylate: A pharmacokinetic evaluation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acridines; Administration, Intranasal; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Epinephrine; Female; Imatinib Mesylate; Injections, Intravenous; Male; Mice, Inbred BALB C; Nasal Mucosa; Pantoprazole; Protein Kinase Inhibitors; Tetrahydroisoquinolines | 2017 |